Overview
Lobbying Costs
100,000€ - 199,999€
Financial year: Jan 2020 - Dec 2020
Lobbyists (Full time equivalent)
1.7 Fte (14)
Lobbyists with EP accreditation
0
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
The Health Policy Partnership (HPP)
EU Transparency Register
223430420230-66 First registered on 08 Jan 2016
Goals / Remit
We are a specialist health policy consultancy. We create innovative policy initiatives and powerful evidence–based communications for organisations across the health spectrum. We provide a unique, seamless approach to help resolve the most complex issues facing our health care systems. We do this through rigorous research and expert synthesis of evidence, inter-sectoral collaboration, and powerful communications that act as the starting point for meaningful changes in policy and practice.
Main EU files targeted
Active and healthy ageing; EU Beating Cancer Plan.
Public health and healthcare policy, specific focus in fragility fractures, heart failure and cancer.Address
Head Office
The Health Policy Partnership 68-69 St Martin's Lane
London WC2N 4JS
UNITED KINGDOMEU Office
The Health Policy Partnership 68-69 St Martin's Lane
London WC2N 4JS
UNITED KINGDOMWebsite
-
People
Total lobbyists declared
14
Employment time Lobbyists 25% 2 10% 12 Lobbyists (Full time equivalent)
1.7
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
Time provided above relates to HPP staff time dedicated to any formal engagement with MEPs, EU officials, or where there is policy activity directly involving or targeting EU institutions - i.e. it excludes general health policy activities where other audiences are our primary targets (e.g. national policy makers, academic experts, clinicians, health providers etc), and global activities.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Professional consultancies
-
Networking
Affiliation
Heart Failure Policy Network - www.hfpolicynetwork.eu
(provide secretariat and lead project)Member organisations
Please see www.hfpolicynetwork.eu
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2020 - Dec 2020
Lobbying costs for closed financial year
100,000€ - 199,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
100,000€ - 199,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
HEART FAILURE POLICY NETWORK (HFPN)
HPP acts as Secretariat for the HF Policy Network, a multidisciplinary group of experts from across Europe working with patients, health professionals and other stakeholders to lead significant policy changes that may improve the lives of people with heart failure (HF). The HFPN has ongoing relationships with several MEPs who donate their time for free to support (and act as Members of) the HFPN.
Relevant activities in 2021:
Heart Failure Policy Summit: online event dedicated to the heart failure policy and advocacy community, aiming to equip and empower national advocates to engage decision-makers on heart failure and cardiovascular disease in their respective countries. It was free to attend and open to anyone. We invited MEPs and EU experts with an interest in the subject to be involved. Billy Kelleher MEP chaired the opening session andJohn F. Ryan (DG Sante) spoke in two sessions.
Action Statement on Heart Failure: a call to action for the European Union to address the growing burden of heart failure. The Action Statement contained detailed policy recommendations for the European Commission, Council of the European Union and European Parliament, linking to existing and forthcoming EU programmes. Billy Kelleher circulated the Action Statement on Heart Failure to several committees in the EP.
Event report from a virtual policy roundtable: summary of a virtual policy roundtable that sought to identify a consensus on future opportunities for supportive heart failure policies from the EU and the potential for actions in heart failure to contribute to the growing debate on cardiovascular disease policy. The event was chaired by an MEP.
RADIOLIGAND THERAPY
HPP established a multi-stakeholder steering committee comprising patient advocates and experts in oncology and nuclear medicine from across Europe, to develop a policy report to raise awareness of radioligand therapy as an innovative component of cancer care. In 2021, we invited MEPs and EU experts, with an interest in the subject, to participate in an online webinar (at the American Society of Clinical Oncology 2021 Conference) which acted as the launch of the Radioligand Therapy Readiness Assessment Framework. In addition, we also invited them to the launch of the readiness in cancer care policy brief and was held in concurrence with the European Society for Medical Oncology 2021 Congress.
LUNG CANCER
HPP organised a webinar to convey the case for investment in lung cancer screening and explore readiness for implementation across Europe. It included a multistakeholder discussion of concrete next steps that are needed from a policy perspective. The webinar was also preceded by the development of an ‘open letter’ sent to the BECA committee in the EP to clearly convey the policy asks of the report with respect to lung cancer screening.
HPP also developed a think piece on helping to increase recognition of lung cancer as a strategic health priority. In addition, it aims to identify specific opportunities to bring lung cancer into the fold of other health policy priority platforms (e.g. non-communicable diseases, socioeconomic inequalities, women’s health etc.).
FRAGILITY FRACTURES
HPP established five building blocks of an effective policy response to the challenge posed by osteoporosis and fragility fractures. We started with desk research and assembled a Working Group and Parliamentary Forum of European experts and policymakers. HPP also interviewed a range of experts, including carer representatives, healthcare professionals and healthy ageing advocates. In 2021, we undertook an EC submission on healthy ageing and fragility fractures. We also supported the Global Heart Hub with their EU submission on healthy ageing (and cardiovascular disease).Other activities
None declared
Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 25 Oct 2023 Location Brussels, Belgium Subject Role of the EU in promoting heart health Cabinet Cabinet of Commissioner Mairead Mcguinness Portfolio Financial services, financial stability and Capital Markets Union Attending - Katherine Power (Cabinet member)